Centene Co. (NYSE:CNC) Shares Sold by Warther Private Wealth LLC

Warther Private Wealth LLC reduced its stake in Centene Co. (NYSE:CNC) by 35.4% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 3,856 shares of the company’s stock after selling 2,114 shares during the period. Warther Private Wealth LLC’s holdings in Centene were worth $234,000 at the end of the most recent quarter.

Other large investors also recently bought and sold shares of the company. Stratos Wealth Partners LTD. lifted its holdings in shares of Centene by 4.1% in the 4th quarter. Stratos Wealth Partners LTD. now owns 4,094 shares of the company’s stock worth $248,000 after acquiring an additional 163 shares during the last quarter. Mount Yale Investment Advisors LLC lifted its stake in Centene by 2.1% during the third quarter. Mount Yale Investment Advisors LLC now owns 8,082 shares of the company’s stock worth $608,000 after purchasing an additional 167 shares in the last quarter. Aptus Capital Advisors LLC grew its stake in shares of Centene by 6.2% in the third quarter. Aptus Capital Advisors LLC now owns 3,722 shares of the company’s stock valued at $280,000 after buying an additional 217 shares in the last quarter. CX Institutional raised its holdings in shares of Centene by 7.3% in the 3rd quarter. CX Institutional now owns 3,919 shares of the company’s stock valued at $295,000 after buying an additional 266 shares during the period. Finally, Forte Capital LLC ADV lifted its stake in Centene by 5.5% during the 3rd quarter. Forte Capital LLC ADV now owns 5,320 shares of the company’s stock worth $400,000 after acquiring an additional 275 shares in the last quarter. Institutional investors and hedge funds own 93.63% of the company’s stock.

Wall Street Analysts Forecast Growth

Several analysts have recently issued reports on the stock. StockNews.com cut shares of Centene from a “strong-buy” rating to a “buy” rating in a research report on Thursday, February 6th. Argus lowered shares of Centene from a “buy” rating to a “hold” rating in a report on Thursday, February 6th. Oppenheimer dropped their price target on shares of Centene from $95.00 to $85.00 and set an “outperform” rating for the company in a research note on Friday, December 13th. Jefferies Financial Group cut Centene from a “hold” rating to an “underperform” rating and reduced their price objective for the company from $68.00 to $52.00 in a research note on Tuesday, December 10th. Finally, UBS Group raised Centene from a “neutral” rating to a “buy” rating and boosted their target price for the stock from $79.00 to $80.00 in a research note on Friday, December 13th. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and ten have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, Centene has a consensus rating of “Moderate Buy” and a consensus price target of $81.31.

Centene Price Performance

Shares of NYSE:CNC opened at $57.36 on Wednesday. Centene Co. has a 12 month low of $55.03 and a 12 month high of $81.42. The firm has a market capitalization of $28.96 billion, a P/E ratio of 9.19, a P/E/G ratio of 0.79 and a beta of 0.45. The company has a debt-to-equity ratio of 0.70, a current ratio of 1.11 and a quick ratio of 1.10. The company’s fifty day moving average price is $61.21 and its 200 day moving average price is $66.91.

Centene (NYSE:CNC) last posted its earnings results on Tuesday, February 4th. The company reported $0.80 earnings per share for the quarter, beating the consensus estimate of $0.49 by $0.31. The business had revenue of $40.81 billion during the quarter, compared to the consensus estimate of $38.78 billion. Centene had a return on equity of 13.85% and a net margin of 2.03%. The business’s quarterly revenue was up 3.4% on a year-over-year basis. During the same period in the previous year, the business earned $0.45 EPS. As a group, sell-side analysts predict that Centene Co. will post 6.97 earnings per share for the current fiscal year.

Insider Activity

In related news, Director Thomas Greco purchased 17,000 shares of the stock in a transaction that occurred on Wednesday, December 18th. The shares were purchased at an average price of $59.75 per share, with a total value of $1,015,750.00. Following the completion of the acquisition, the director now directly owns 19,309 shares in the company, valued at $1,153,712.75. This represents a 736.25 % increase in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director H James Dallas acquired 1,693 shares of Centene stock in a transaction on Monday, December 16th. The shares were bought at an average cost of $59.01 per share, with a total value of $99,903.93. Following the completion of the purchase, the director now owns 1,693 shares in the company, valued at $99,903.93. The trade was a ∞ increase in their ownership of the stock. The disclosure for this purchase can be found here. Over the last ninety days, insiders bought 23,693 shares of company stock valued at $1,409,954. 0.33% of the stock is currently owned by company insiders.

Centene Company Profile

Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children’s health insurance program, foster care, medicare-medicaid plans, long-term services and support.